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Abstract 
Does Verbal Communication Impairment Affect Quality of Life 
in Amyotrophic Lateral Sclerosis Patients? 
The purpose of this study was to examine the self-
perceived QOL in ALS patients. Literature will be presented 
on the incidence, prevalence, prognosis, diagnosis and 
management of ALS, QOL studies for ALS, the role of the 
multidisciplinary team, the impairments and dysfunction 
that ALS patients experience, communication issues, and the 
development of ALS specific instruments to measure QOL. 
The "bulbar dysfunction" that ALS patients experience 
in salivation management, speech, and swallowing were 
examined in detail. The objectives of this research study 
were to investigate the following hypotheses: 1. QOL will 
differ among ALS patients with varying levels of speech, 
swallowing, and salivation functioning, 2. Patients wit~ 
less impairment in these aspects of physical functioning 
will report better QOL. 
Archival data was obtained from a validation study for 
the ALSSQOL instrument that employed 7 university-based ALS 
centers. ANOVA revealed that self-reported QOL varied 
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according to level of functioning for speech F (4,333) 
5.13, p =.001; swallowing F(4, 333)= 6.88, p=.OOO; and 
salivation, F(4,333)= 3.75, p =.000. 
This research is important because it showed that QOL 
is adversely affected by impaired communication abilities. 
Having this knowledge will allow mental health providers to 
tailor time-sensitive interventions more appropriately, 
perhaps enhancing ALS patients' QOL. 
Areas of future consideration include utilization of 
the ALSSQOL for longitudinal studies and for investigation 
of ALS patients' mindsets as they prepare to experience 
each of the transitions during this predictable disease 
process. 
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Introduction and Literature Review 
Statement of the Problem 
Although it is an uncommon disease, Amyotrophic 
Lateral Sclerosis (ALS) has strong celebrity ties and often 
receives a fair amount of media attention. Famous sufferers 
of ALS, such as Lou Gehrig and Stephen Hawkings have 
created national and worldwide awareness of the disease. 
Despite its infrequency, ALS has attracted a great deal of 
attention in many different ways. 
Recently ALS has been spoken about in the news because 
of reports that there is evidence of elevated 'incidences in 
those who served in the 1991 Gulf War. Research on this 
topic is ongoing. 
Mitch Alborn's bestseller, Tuesday's with Morrie, is a 
true story about a student rekindling his relationship with 
his former mentor after learning that the mentor has ALS. 
In February of 2006, Oscar-nominated actor James Woods 
played a wheelchair bound doctor suffering from ALS on the 
hit medical drama, ER. As his character's condition worsens 
he becomes forced to utilize an electronic device to help 
him speak. 
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Although there has been increased attention on ALS in 
the news and entertainment industry, the attention that ALS 
has received from the medical community has been even more 
extensive in recent years. The increased focus has been on 
such issues as diagnostic considerations (Brooks, Miller, 
Swash & Munsat, 2000), multidisciplinary approaches to care 
(Lechtzin, Schmidt & Clawson, 2005; Traynor, Alexander, 
Corr, Frost & Hardiman, 2003), medical progress (Rowland & 
Shneider, 2001), and quality of life (QOL; Simmons, 2005; 
Lo Coco, Lo Coco, Cicero, Oliveri, Lo Verso, Piccoli, et 
al., 2005; Chio, Gauthier, Montuschi, Calvo, DiVito, 
Ghiglione, et al., 2004; Bremer, Walsh, Simmons & Felgoise, 
2004; Walsh, Bremer, Felgoise & Simmons, 2003). 
Precise attention will be paid to the concept of 
quality of life throughout this text. QOL is a difficult 
concept to discuss because there is no consensual 
definition. Advertising executives, real estate agents and 
politicians alike inform the public about how they can 
improve quality of life by buying a specific product, 
living in a specified area or voting for a particular 
candidate. The concept of QOL is also used extensively 
throughout the healthcare system. Research can be found 
applying the concept in the fields of nursing, medicine and 
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other allied disciplines. Over the past three decades 
thousands of articles related to QOL have been published. A 
brief literature review revealed papers on QOL related to 
diabetes, obesity, pulmonary disease, cerebral vascular 
accident, systemic lupus, sarcoidosis, gastroesophageal 
reflux disease and an assortment of other illnesses of 
varying severity. 
The purpose of the current study will be to examine 
the self-perceived QOL in ALS patients. Precise focus will 
be on verbal communication impairment and the effect that 
this impairment has or does not have on QOL. Literature 
will be presented on such issues as the incidence, 
prevalence and prognosis of ALS, the diagnosis and 
management of ALS, QOL studies for ALS, the role of the 
multidisciplinary team in working with ALS patients, the 
impairments and dysfunction that ALS patients experience, 
communication issues, and the development of ALS-specific 
instruments to measure QOL. 
The "bulbar dysfunction" that ALS patients experience in 
salivation management, speech, and swallowing will be 
examined in detail. ALS presents in various ways. It is 
possible that some patients will have the symptoms of 
bulbar dysfunction early in the course of their illnesses, 

Communication & QOL in ALS 4 
on the other hand, others will not manifest such symptoms 
until later in the disease progression. 
The objectives of this research study are to investigate 
the following hypotheses: 
1. QOL will differ among ALS patients with varying 
levels of speech, swallowing, and salivation functioning, 
2. Patients with less impairment in these aspects of 
physical functioning will report better QOL. 
ALS Information 
What is ALS? 
Amyotrophic lateral sclerosis (ALS) is an inexorable, 
rapidly progressive, neurological disease that is 
consistently fatal. It affects nerve cells in the brain and 
the spinal cord that control voluntary muscle movement. 
French neurologist Jean-Martin Charcot initially 
described the disease in the 19th century and named it 
amyotrophic lateral sclerosis. Amyotrophic refers to the 
muscle atrophy, weakness, and fasiculations that suggest 
disease of the lower motor neurons. Lateral sclerosis 
refers to the hardness observed when palpating the lateral 
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columns of the spinal cord in autopsy specimens (Rowland & 
Shneider, 2001). 
Amyotrophic is derived from the Greek language, "A" 
meaning no or negative, "myo" referring to muscles, and 
"trophic" meaning nourishment; therefore, it literally 
means "no muscle nourishment" (The ALS Association, 2006) . 
In the United States of America it is generally referred to 
as "ALS" or "Lou Gehrig's disease". Lou Gehrig, the "Iron 
Horse", was a professional baseball player for the New York 
Yankees who was the epitome of reliability and consistency. 
Gehrig set a record by playing in a consecutive streak of 
2,130 professional baseball games throughout his career, 
despite sustaining 17 fractures in his hands, having severe 
back pain and suffering various other illnesses and minor 
injuries. A columnist once referred to him as a "symbol of 
indestructibility ... a Gibraltar in cleats." However, in 1939 
he hastily retired "for the good of the team" after he 
realized that he was not playing well and that something 
was wrong, physically. A few months later he was diagnosed 
with ALS; two years after the diagnosis he was dead. This 
point serves to elucidate the facts that not only does ALS 
fail to discriminate but also that it serves to severely 
debilitate in a relatively short time. 
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In the United Kingdom and elsewhere, the umbrella term 
motor neuron disease (MND) is more commonly used to 
describe this combination of upper and lower motor neuron 
dysfunction (Talbot, 2002). There are, however, forms of 
motor neuron degeneration that selectively affect upper or 
lower motor neurons; however, they will not be the focus of 
this discussion or investigation. 
ALS results in the diffuse degeneration and death of 
motor neurons, leading to muscle atrophy, which invariably 
culminates in respiratory insufficiency and eventually 
death (Lechtzin, Schmidt & Clawson, 2005; Simmons, 2005). 
Before death, which at this time seems the unavoidable 
consequence of the disease, the patients' muscles gradually 
deteriorate, waste away, and twitch. Muscle strength erodes 
and all voluntary muscle control is ultimately lost. The 
inevitable respiratory insufficiency secondary to the 
impairment of the respiratory musculature is the most 
frequent cause of death in patients with ALS (Farrero, 
Prats, Povedano, Martinez-Matos, Manresa & Escarrabill, 
2005). 
The clinical presentation of ALS depends on the area 
of the nervous system that has been damaged. ALS can 
present primarily with limb involvement, yet bulbar 
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symptoms are exhibited initially in 19% to 25% of ALS cases 
(Walling, 1999). 
Because of the harsh reality that ALS cannot be cured 
or its progression halted, the primary goal in treating 
patients with ALS is often palliative in nature. Optimizing 
quality of life is the main focus of patient management 
(Simmons, 2005). 
Incidence, Prevalence and Prognosis 
There has been a push in recent years to establish a 
national registry that would promote a better understanding 
of ALS. Legislation is currently pending to establish a 
national registry here in the United States. Among other 
things, a single registry would allow for data collection 
on incidence and prevalence, environmental and occupational 
factors that may be associated with the disease, the age, 
race/ethnicity, gender and family history of individuals 
diagnosed with the disease. Presently, it is estimated that 
as many as 30,000 Americans have the disease at any given 
time. The prevalence is believed to be six to eight persons 
per 100,000 (ALS Association, 2006). The incidence in the 
United States is somewhat over 5,600 newly diagnosed cases 
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per year. Lechtzin, Schmidt and Clawson (2005) report an 
estimated 1 death in every 800 adult males in the United 
States is attributable to ALS. 
The worldwide incidence of ALS is estimated to be 0.6 
to 2.6 cases per 100,000 people annually. The male to 
female ratio is 1.6:1, and the onset occurs most frequently 
in the sixth decade of life. However, there have been cases 
of ALS affecting teenagers and octogenarians (Lechtzin, 
Schmidt, & Clawson, 2005). 
Despite recent advances in research and medical care, 
the prognosis unfortunately remains poor for patients with 
ALS. Simmons (2005) reports that the median time from onset 
of symptoms until death has been found to be 23 to 48 
months. Five-year survival rates have been published, 
ranging from 9% to 40%, and 10-year survival rates are 
between 8% and 16%. The annual mortality rate attributed 
to ALS is two deaths per 100, 000 in the U.S. (For shew & 
Hulihan, 2005) 
In 90% to 95% of all ALS cases, the disease 
presentation appears arbitrary with no clear associated 
risk factors, such as family history. However, 
approximately 5%-10% of all cases are inherited. This 
familial form of ALS requires only one parent to carry the 
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gene accountable for the disease (National Institute of 
Neurological Disorders [NINO], 2006). 
Turner, Parton, Shaw, Leigh and Al-Chalabi (2003) put 
forth that those who present with initial bulbar onset, 
onset later in life or in the definite El Escorial category 
are not automatically precluded a long survival. However, 
those ALS patients who present at a younger age or with 
pure upper motor neuron signs initially have a better 
prognosis. 
Diagnosis of ALS 
Sadly, ALS can be a very difficult disease to 
diagnose. The average delay from symptom onset to a 
definitive diagnosis is about 14 months. Now and again 
there may be occasional incidences of a patient surviving 6 
months or even less following his or her diagnosis (Leigh, 
Abrahams, Al-Chalabi, Ampong, Goldstein, Johnson, et al., 
2003). Often patients' initial symptoms may lead them to 
believe that what they are experiencing is indicative of 
the normal aging process or arthritis and other such 
disorders. They may spend time researching possible 
etiology on the Internet. Quite possibly they may even 
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present to their primary care providers with vague somatic 
complaints that do not lead to the consideration of ALS as 
the source. The regrettable fact that there is no specific 
diagnostic test such as neuroimaging studies or specific 
laboratory procedures, makes it sometimes difficult to 
diagnose ALS even after the patient presents to the 
appropriate healthcare professionals. However, the presence 
of upper and lower neuron signs in a single limb is 
strongly suggestive of the disorder. Ultimately, the 
diagnosis can be made from a combination of clinical and 
neurophysiological assessments (Winhammer, Rowe, Henderson, 
& Kiernan, 2005). 
Management Strategies for ALS 
Breaking the News. The single most important indicator 
of how the client is going to react to the diagnosis and 
eventually collaborate with his or her healthcare providers 
is dependent upon the manner in which the diagnosis is 
conveyed by the physician (Simmons, 2005). Leigh and 
colleagues (2003) previously recognized this fact and 
reported that the experience of being informed that the 
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diagnosis is ALS shapes the subsequent relationships that 
the client will have with the healthcare team. 
Respiratory Issues. The management of respiratory care 
is quite possibly the biggest challenge that the healthcare 
team faces in the care of ALS patients. The majority of ALS 
patients will die because of progressive respiratory 
failure. Thorough pulmonary evaluation is necessary because 
of the inconspicuous nature of presenting symptoms. For 
example, patients may have extremity involvement prior to 
overt respiratory issues. They may be confined to 
wheelchairs and be unable to exert themselves to the point 
of dypsnea (Lechtzin, Schmidt & Clawson, 2005). An early 
understanding of patients' preferences will make difficult 
decisions such as the initiation of invasive ventilation 
easier to broach, in a timely manner (Miller, Rosenberg, 
Gerlinas, Mitsumoto, Newman, Sufit, et. al., 1999). 
Nutritional Issues. "Dysphagia" is the difficulty in 
swallowing or the inability to swallow. ALS patients with 
dysphagia are very likely to experience insufficient fluid 
intake and suboptimal caloric intake (Simmons, 2005; 
Lechtzin, Schmidt & Clawson, 2005; Miller, Rosenberg, 
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Gerlinas, Mitsumoto, Newman, Sufit, et al., 1999). Initial 
management includes the modification of food and fluid 
consistency. Patients with bulbar dysfunction generally 
present with jaw and tongue weakness and fatigue, drooling, 
choking, and slow intake of food; meal times must be 
handled deliberately. Malnutrition, dehydration, 
aspiration, weight loss, and infection become serious 
issues. Patients may lose weight because they eat more 
slowly and ultimately eat less than they did before. This 
occurs perhaps, even more in the presence of others due to 
the embarrassment caused by excessive saliva, sputtering, 
coughing, and food falling out of their mouths. They also 
often depend on others to assist them with eating; this is 
due to extremity weakness that leads to difficulty cooking 
and even feeding oneself (Leigh, Abrahams, Al-Chalabi, 
Ampong, Goldstein, Johnson, et al., 2003). 
When the initial management issues are no longer 
effective then the insertion of a feeding tube, 
percutaneous endoscopic gastrostomy (PEG), must be 
considered (Simmons, 2005; Lechtzin, Schmidt & Clawson, 
2005; Miller, Rosenberg, Gerlinas, Mitsumoto, Newman, 
Sufit, et al., 1999). A dietician best carries out the 
dietary assessments; however, close collaboration with 
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speech and language therapists is recommended when dealing 
with dysphagia (Leigh, Abrahams, Al-Chalabi, Ampong, 
Goldstein, Johnson, et al., 2003). 
Psychological Issues. ALS is a disease that is clearly 
dynamic, yet maintains a fairly predictive course. This 
predictability allows for preparation of the many losses 
that will befall the ALS patient and his or her family. 
The role of a mental health professional is invaluable on 
the ALS multidisciplinary team due to the scope of real and 
perceived losses. Lechtzin, Schmidt and Clawson (2005) 
identify a succession of losses, such as independence, role 
identity, and future plans that put the patient at risk for 
periods of grief and mourning as he or she addresses each 
new phase of the disease. Grief is a complicated, 
individual process that cannot be well predicted. Yet 
healthcare professionals should be prepared for the patient 
and his or her support team to progress through varying 
periods of denial, anger, bargaining, depression and 
acceptance at his or her own rate and in no particular 
order (Kubler-Ross, 1973). 
Lou, Reeves, Benice and Sexton (2003) affirm that 
depression is associated with a poor QOL and must be 
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treated as a priority. Viable interventions include both 
psychopharmacological and psychotherapeutic options. 
Support systems and available resources must be readily 
identified and then involved in the treatment process. 
Emotional lability. ALS patients exhibit emotional 
lability that could be easily misconstrued as symptoms of a 
mood disorder. Pathological crying or laughing is observed 
in as many as 50% of ALS patients. The emotions exhibited 
are disproportionate or inappropriate to internal feelings 
or external stimuli. The abnormal affective display is not 
well understood. Although not definitively indicative of a 
mood disorder, antidepressants such as selective serotonin 
reuptake inhibitors (SSRis) are often used to treat the 
emotional lability. 
Pain Management. It is common for ALS patients to feel 
as if their pain will be protracted and uncontrolled 
(Hindelang, 2006). Between 40% and 73% of ALS patients 
experience pain in the later stages (Miller, Rosenberg, 
Gelinas, Mitsumoto, Newman, Sufit, et al., 1999). Pain in 
the early stages of ALS, although less frequent, still 
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occurs and is attributed chiefly to spasticity and cramping 
(Simmons, 2005). 
Pain should be regularly assessed and the patient's 
perception of pain should be continually evaluated. 
Anxiety, stress, frustration, depression, poor sleep, and 
fatigue can all contribute to varying manifestations of 
pain. 
End-of-Life Issues. The end of life is a very critical 
phase of treatment for ALS patients. Patients and families 
need to feel completely supported. Perhaps more than any 
other time during the course of treatment, religious and 
cultural beliefs need to be recognized fully. 
There are a great number of ethical and legal issues 
involved when working with ALS patients. Healthcare teams 
should be fully aware of contemporary literature regarding 
euthanasia and physician-assisted suicides. Lechtzin, 
Schmidt and Clawson (2005) suggest discussing advance 
directives as soon as rapport has been established with the 
patient and family. Advanced directives are most likely in 
the form of a living will, a durable power of attorney for 
health care matters, or a note written and signed by the 
physician in the medical records, documenting the desires 
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of the patient or surrogate decision maker (Vasar, 
Weinacker, Henig & Raffin, 2002). 
Caregiver Issues. Communication among the healthcare 
team helps to avoid any perceived ethical dilemmas that may 
arise. Depression and anxiety may be just as relevant for 
the caregivers as for the patients. 
A recent trend has developed in which researchers have 
become increasingly interested in the QOL for caregivers of 
those with ALS. The strong connection between ALS patients 
and their caregivers, perhaps more so than in other dyads 
facing terminal illnesses, has lead the research to 
naturally progress in this direction. 
Brbmberg and Forshew (2002) put forth the notion that 
there is likely a response shift by patients that leads to 
an eventual difference between caregiver and patient, 
relative to the way in which QOL is viewed. They posit that 
during the course of the disease the patients change their 
terms or internal standards of reference used to judge QOL. 
In other words, what they previously viewed as important to 
maintaining QOL has now changed. This can actually be 
viewed as a positive coping mechanism. However, these 
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response shifts have made the measurement of QOL in ALS 
patients more difficult. 
An often neglected area of discussion is the level of 
sexual activity for ALS patients. This is unfortunate 
because there is a realistic potential for normal sexual 
functioning. Sexual function is not directly affected; 
however, such issues as patient and partner passivity and 
decreased libido create obstacles. Most frequently the 
reasons reported for change in sexual activity include 
decreased physical strength and body image issues (Wasner, 
Bold, Vollmer & Borasio, 2004). Massage, shiatsu, 
reflexology and the scheduling of private time should be 
discussed as viable options for the couple. Encouraging the 
open discussion of such sensitive issues can serve to 
improve the quality of the couple's relationship and delay 
what may have already been viewed as a loss. This open 
discussion should take place before a significant loss of 
the patient's communication ability has taken place. It is 
a very sensitive and perhaps awkward topic to discuss and 
it may be made even more difficult to handle when 
complicated by an impaired ability to communicate clearly. 
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Bulbar Dysfunction in ALS 
The term bulbar refers to the motor neurons located in 
the bulb region of the brain stem that control the muscles 
of chewing, swallowing, speaking and the capability of 
maintaining an open upper airway. The following pages will 
discuss the QOL issues that ALS patients must address when 
faced with bulbar dysfunction. 
Excessive Salivation 
Excessive salivation that is beyond a patient's 
ability to compensate for is known as sialorrhea. 
Sialorrhea can affect upwards of 20% of ALS patients. It 
can be socially debilitating and is particularly 
problematic for patients with significant bulbar 
involvement. The actual problem with sialorrhea is the 
inability to control and swallow one's saliva. Saliva 
production is actually not increased in ALS patients; 
rather, it is decreased (Miller, Rosenberg, Gelinas, 
Mitsumoto, Newman, Sufit, et al., 1999). It is unclear why 
saliva production is decreased. Weak muscles around the 
mouth, tongue, and throat can compromise the handling of 

Communication & QOL in ALS 19 
saliva in the mouth and impair the swallowing mechanism. It 
is quite possible that difficulty in swallowing leads ALS 
patients to restrict fluid intake, thus causing them to 
become dehydrated. Therefore they will produce less saliva. 
However, the little saliva that they do produce may still 
be difficult for them to manage. It is a difficult problem 
because once they become dehydrated feeding tubes may be 
placed to rehydrate and the sialorrhea can be exacerbated. 
Sialorrhea can cause significant distress to the 
patient and caregivers because of the resulting drooling, 
choking, coughing, gagging, sputtering, and vomiting. The 
excessive drooling creates concern because ALS patients are 
at increased risk of aspiration, pneumonia, skin break 
down, and infections. When speech is impaired and 
communication devices are utilized, the excessive saliva 
can actually make the equipment wet and cause damage 
(Mathur & Vaughn, 2006) . 
Sialorrhea is categorized either as primary or as 
secondary. Primary sialorrhea causes drooling due to 
hypersecretion of the salivary glands. ALS patients' 
drooling is most likely due to secondary sialorrhea caused 
by impaired neuromuscular control with dysfunctional 
voluntary oral motor activity. The patient's inefficient 
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and infrequent swallowing further compounds the problem of 
sialorrhea (Mathur & Vaughn, 2006) . Dehydration is a viable 
risk for ALS patients with salivation issues. Excess saliva 
can be further increased by anxiety, hunger and acid 
reflux. There are various medications and surgical 
procedures utilized to treat excess salivation. 
Because of nasal congestion and fatigue of the jaw 
muscles, ALS patients may resort to breathing through their 
mouths more often than through their noses. This can create 
complications such as the thickening of their saliva. This, 
paired with the side effects of certain medications that 
also cause dryness and thickening, results in postnasal 
drip, chronic cough and the constant need to clear one's 
throat. In addition to these potential medical issues this 
writer believes that an ALS patient's QOL is adversely 
affected by complicated and awkward social situations 
created by their impaired saliva management. 
Speech Impairment 
There are many losses involved with ALS. The loss of 
one's mobility, independence, future, and what is arguably 
one of the most devastating losses, the ability to speak. 
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In the bulbar form of ALS, speech problems are most common 
and can present as slurring, hoarseness or decreased 
volume. The initial symptoms are often a slight, 
intermittent slurring that can occur when the client is 
tired or has been speaking a lot on a particular day. Over 
time the ALS patient's speech slowly becomes more and more 
unintelligible as the functioning of the tongue, lips and 
pharynx become more impaired (Simmons, 2005). 
The classification of ALS is determined by the site of 
involvement (upper motor neuron versus lower motor neurons) 
and depends upon the involvement of spinal nerves or bulbar 
nerves. The bulbar symptoms are the initial manifestations 
in 19 to 25% of all ALS cases (Walling, 1999). Bulbar 
involvement in ALS is most often a combination of upper and 
lower motor neuron dysfunction. This combination results in 
mixed dysarthria with both spastic and flaccid components 
affecting muscles of the face, tongue, and throat (Simmons, 
2005). Dysarthria is a neurologically based speech disorder 
that results in weakness or spasticity of the lips, tongue, 
jaw movement, soft palate and respiratory muscles (Carr-
Davis, Blakely-Adams, & Corinbilt, 2005). Dysarthric speech 
is characterized by problems with articulation, volume and 
quality of speech, and prosody (speech rate, rhythm and 
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naturalness; Yorkston, 1999). Unfortunately many ALS 
patients can develop anarthria (loss of motor ability to 
speak) within just a few months (Leigh, Abrahams, Al-
Chalabi, Ampong, Goldstein, Johnson, et al., 2003). 
Stages of Severity of Dysarthria in ALS. Yorkston and 
colleagues (1993) put forth a five-stage model for the 
severity of dysarthria in ALS. For each of the five stages 
there are treatment interventions outlined. The underlying 
strategy for each stage is to maintain functional 
communication with natural speech or augmentative 
communication strategies, regardless of the severity of the 
speech disorder. The five-stage model is as follows 
(Yorkston, Strand, Miller, Hillel & Smith, 1993): 
Stage 1: Normal speech processes. 
Stage 2: Detectable speech disturbances. 
Stage 3: Behavioral modifications. 
Stage 4: Use of augmentative communication. 
Stage 5: Loss of useful speech. 
Individuals in the first stage do not demonstrate 
overt speech changes. Normal rate and volume of the 
patient's speech is preserved. The level of change may be 
noticeable only to the client or perhaps to his or her 
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spouse (Yorkston, Beukelman & Ball, 2002). Interventions at 
this time should be focused around providing information to 
the patient and family. This first stage can be used as a 
preparatory time of education regarding the disease course. 
The inevitable loss of speech must be fully explored and 
the patient and family should be made aware of the choices 
they will have to make in the future. Ideally the decision-
making relative to communication devices should occur while 
the patient still retains the ability to speak (Yorkston, 
Beukelman & Ball, 2002). 
The second stage of dysarthria in ALS is marked by 
detectable speech disturbances. Although there are overt 
changes that listeners will recognize, the patient's speech 
does remain intelligible. However, these changes in rate, 
articulation and resonance will be exacerbated during 
periods of fatigue or stress (Yorkston, Beukelman & Ball, 
2002). Environmental control is among the interventions to 
be utilized during this stage of impairment. Background 
noise may lead to the ALS patient's having to speak louder. 
If this is even possible, the experience can be very 
fatiguing. Both background noise and distance may need to 
be reduced when interacting with ALS patients (Yorkston, 
Beukelman and Ball, 2002). Turning off the television and 
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any other mechanical equipment, such as kitchen appliances 
and non-vital medical equipment may be necessary for a 
brief period during predetermined conversation time. Effort 
should be placed on establishing clarity when conversing 
with an ALS patient. It is vital to confirm the context of 
the discussion prior to changing a topic or ending a 
conversation. Additionally, ALS patients will find it very 
difficult to partake in group discussions and may tend to 
shun social gatherings altogether. Another relevant issue 
is the fact that a great number of ALS patients and their 
partners are elderly and may have experienced some level of 
hearing loss (Yorkston et al., 2002). Hearing loss is 
certain to make the deciphering of impaired speech even 
more difficult. 
Stage three is marked by reduction in intelligibility. 
Frequent communication breakdowns will occur in stage 
three, particularly while in adverse listening conditions. 
Messages will often need to be repeated to resolve these 
communication breakdowns (Yorkston, Beukelman and Ball, 
2002). Interventions during this stage focus on behavior 
modifications. Optimizing speech performance and using 
compensation techniques are the main themes in stage three. 
However, environmental control is once again stressed 
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during this stage of impairment. The optimization of speech 
performance starts by encouraging the ALS patient to slow 
his or her rate of speech (Yorkston, Beukelman and Ball, 
2002; Yorkston & Beukelman, 2000). ALS patients are 
encouraged to exaggerate their speech. In particular, words 
that are important to the context of what they are trying 
to say must be overemphasized. Incorporated into the stage 
three approach is training in energy conservation. 
Attention is given to avoiding fatigue because it can have 
a substantial impact on the quality of an ALS patient's 
speech. Whenever possible the ALS patient should refrain 
from attempting communication in less than ideal 
situations. The goal is to avoid a reduction in the 
efficiency of the patient's speech muscles. This may 
involve recognition on the part of the listener to suggest 
such actions as changing locations; an example of this may 
be finding a quieter area in a restaurant. 
Stage four is marked by the patient's reliance on 
augmentative systems. Devices are used either as the 
patients' primary or secondary means of communication. When 
natural speech is not understood the patient uses his or 
her device as a supplement. Augmentative systems may be 
used to provide information about a topic, present the 
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first letter of a word, or to "verbalize" a word or phrase 
that is unusual or difficult to enunciate (Yorkston & 
Beukelman, 2000). 
Although the patient can still speak using residual 
speech, the transition to augmentative communication 
approaches is complete during this stage. This transition 
period is extremely crucial in the management of patients 
with ALS (Yorkston, Beukelman and Ball, 2002; Yorkston & 
Beukelman, 2000). It is fundamental that the patient and 
family are supported and educated appropriately during this 
stage of speech impairment. There may be confusion, 
frustration, anger, and even guilt ("Why did I not speak my 
mind when I had the chance?") . 
The fifth stage is characterized by the loss of 
functional speech. The ALS patient is now at a point during 
which the ability to use natural speech as a functional 
means of communication has been lost. At this point the 
patient has become totally dependent upon augmentative 
communication strategies (Yorkston, Beukelman and Ball, 
2002; Yorkston & Beukelman, 2000). 
Individuals will have to use a variety of strategies 
to meet their communication needs. Included among these 
strategies is the development of a non-fatiguing and 
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reliable means of indicating "yes" or "no". This is an 
absolutely mandatory component of an effective management 
plan for dysarthria. Eye gaze is often utilized as a method 
of selection when the ALS patient has lost the ability to 
move his or her head or his or her hands in a dependable 
manner. This may involve the family, partner or caregivers 
being trained to recognize and decipher the intricate and 
subtle aspects of eye gaze communication techniques. 
Additional strategies to be utilized during the fifth stage 
include low-tech picture and alphabet boards. Still other 
strategies involve the use of progressive, computer-based 
systems (Yorkston, Beukelman and Ball, 2002; Yorkston & 
Beukelman, 2000). 
Swallowing Dysfunction 
Weakness and poor control of the mouth and throat 
muscles can result in difficulty swallowing, or dysphagia. 
ALS patients with dysphagia are at risk for insufficient 
nutrition and dehydration that can exacerbate muscle 
atrophy, weakness, loss of coordination and fatigue. 
Swallowing is a complex process that occurs in three 
different stages: oral phase, pharyngeal phase, and 
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esophageal phase. During the first phase (oral phase) the 
tongue moves the food around the mouth for chewing and then 
towards the throat. The second stage (pharyngeal phase) 
begins when the swallowing reflex is triggered by food 
moving to the back of the mouth. The food then passes 
through the pharynx that connects the mouth and the 
esophagus. The larynx closes tightly and breathing is 
ceased to prevent food or liquid from entering the lungs. 
If food does enter into the airway it is known as 
aspiration. This is a dangerous situation for the ALS 
patient. Food or liquid entering the lungs can lead to the 
development of a bacterial infection and subsequently what 
is known as aspiration pneumonia, which can further 
complicate the swallowing process. The third stage 
(esophageal phase) is the point at which food enters the 
esophagus and is carried towards the stomach. Dysphagia can 
occur during any of these different stages. 
There are varied muscles that are part of the 
swallowing process; therefore, the presenting problems can 
vary depending on the particular muscles that have been 
affected. Hillel and Miller (1989) have identified a 
pattern of affected musculature during the course of bulbar 
ALS. Their research identified the fact that the pattern of 
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dysfunction begins with the tongue and lips. This can lead 
to the possibility of oral stage difficulties, such as 
sucking, chewing and moving the food or liquid around the 
mouth towards the throat (Watts & Vanryckeghem, 2001). 
Dysphagia in ALS usually begins with a noticeable 
variation in the ability to manage certain foods. The 
initial changes are usually reported as difficulty managing 
foods that require a lot of chewing (meat), difficulty with. 
foods that fragment easily (crackers), and problems with 
thin liquids (especially room temperature water; Hillel, 
Dray, Miller, Yorkston, Konikow, Strande, et al., 1999). 
The five stage model is as follows (Hillel & Miller, 
198 9) : 
Stage 1: Normal eating habits 
Stage 2 : Early eating problems 
Stage 3: Dietary consistency changes 
Stage 4 : Needs tube feedings 
Stage 5 : Nothing per oral 
Quality of Life 
Definitions 
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Various definitions exist to explain what is meant by 
QOL. Additionally, there has been no clear consensus about 
which instruments provide the best assessment of QOL, 
despite the fact that it is widely recognized as an 
important area of focus. 
In 1997 the World Health Organization defined QOL as 
"individuals' perception of their position in life in the 
context of the culture and value systems in which they live 
and in relation to their goals, expectations, standards and 
concerns. It is a broad ranging concept affected in a 
complex way by the person's physical health, psychological 
state, level of independence, social relationships, 
personal beliefs and their relation to salient features of 
their environment" (WHO, 1997). 
This is an idea that is different from those that have 
been put forth previously in the literature, mainly in 
those studies outside of ALS research in which greater 
emphasis has been placed on physical functioning as an 
indicator of QOL. An important caveat here is that those in 
good health generally underestimate the QOL of those with 
chronic diseases. Also noteworthy is the fact that two 
individuals with similar pathology may have completely 
different QOLs. Simmons and colleagues have posited that 
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QOL in ALS is determined by a broad array of factors and is 
maintained as a patient's physical function declines 
(Walsh, Bremer, Felgoise, & Simmons, 2003; Robbins, 
Simmons, Bremer, Walsh & Fischer, 2001). However these 
studies have looked at physical functioning only as an 
aggregate. The current study will look specifically at the 
effects of impairment in communication on ALS patients' 
QOL. 
Quality of Life Instruments 
World Health Organization (WHO): WHOQOL-100/WHOQOL-
BREF. As mentioned previously, there has been an expanded 
focus in the measurement of health beyond traditional 
health indicators such as mortality and morbidity. There 
is now increased attention given to such issues as disease 
impact, impairment of daily activities and behaviors (World 
Health Organization Group, 1998). 
This new focus has led to the World Health 
Organization Quality of Life (WHOQOL) project, initiated in 
1991. WHO's commitment towards promoting cross cultural 
holistic health care led to interest in developing a QOL 
assessment instrument that would function effectively as an 
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international measure for QOL. The instrument which was 
eventually developed, the WHOQOL-100, assesses individuals' 
perceptions from a frame of reference that incorporates 
their cultures and value systems and their personal goals, 
standards and concerns. The initial conceptual framework 
for the WHOQOL-100 proposed that the 24 facets relating to 
QOL should be grouped into 6 domains. However, subsequent 
analysis of the data showed a four-domain solution to be 
more appropriate. The resulting instrument based on this 
four-domain structure is the WHOQOL-BREF, composed of 26 
items, which measure the following broad domains: Physical 
Health, Psychological Health, Social Relationships, and 
Environment. This new broad focus marks the emergence of 
measures assessing the impact of disease; however, they do 
not encompass the idea of QOL. 
McGill Quality of Life Questionnaire. The McGill 
Quality of Life (MQOL) Questionnaire is relevant to all 
phases of the disease course for people with a myriad of 
life-threatening illnesses. The MQOL was initially 
designed to measure the subjective well-being of cancer 
patients and HIV infected patients by reflecting the 
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patient's experienced QOL (Robbins et al., 2001; Cohen, 
Mount, Strobel, & Bui, 1995). The authors of the MQOL 
attempted to address the identified shortcomings of other 
QOL instruments; therefore, the MQOL differs from previous 
QOL questionnaires in three ways. The first difference is 
that the physical domain was considered an important but 
not predominant aspect of the measure. Second, the positive 
contributions to QOL were measured. Last, the existential 
domain that reflects a patient's perception of purpose, 
meaning in life and the capacity for personal growth was 
measured. The MQOL consists of 16 items organized into five 
subscales: Physical Symptoms, Physical Well-Being, 
Psychological, Existential, and Support. The 16 Items are 
scored from 0 (worst) to 10 (best; Robbins et al., 2001; 
Cohen, Mount, Strobel, & Bui, 1995). 
Sickness Impact Profile. The Sickness Impact Profile 
(SIP) is a general quality of life scale. It consists of 
136 items that measure 12 distinct domains of QOL: 
Ambulation, Movement and Mobility, Body Care, Social 
Interaction, Communication, Alertness, Emotional Behavior, 
Sleep, Eating, Work, Household Management and Recreation. 
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The SIP can be administered by an interviewer or can be 
taken by the patients themselves. Although it is easy to 
administer and score, it is relatively time-consuming, 
taking approximately 30 minutes to complete. Patients 
identify statements that most accurately communicate their 
experiences. All of the 136 items are weighted, depending 
on the severity of dysfunction. A higher score indicates 
greater dysfunction. The SIP, however, is a generic 
instrument that is applicable to a variety of diseases and 
not specific to the distinct issues that ALS presents. 
Sickness Impact Profile/ALS-19. A subset of the SIP is 
the SIP/ALS-19. It is an example of a modified, established 
instrument utilized to address the unique aspects of ALS 
(Bromberg & Forshew, 2002). The SIP/ALS-19 is a 
questionnaire that consists of 19 items chosen from the 
full 136-item SIP. These 19 items were chosen because they 
were believed to have the greatest impact on QOL. The 
scores on this instrument correspond closely to measures of 
strength and function (Robbins, Simmons, Bremer, Walsh & 
Fischer, 2001). The SIP/ALS-19 was developed because of its 
ability to predict changes in function as measured by the 
Tufts Quantitative Neuromuscular Examination (TQNE). The 
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TQNE is a standardized tool for measuring muscle strength 
and pulmonary function in patients with ALS (McGuire, 
Garrison, Armon, Barohn, Bryan, Miller, et al., (1996). 
ALS Assessment Questionnaire. The ALSAQ-40 is a 
disease-specific, health-related QOL instrument for use in 
patients with ALS or other motor neuron diseases. Patients 
are asked to give one of five possible answers to a series 
of forty questions. The instrument covers five dimensions 
of health status that are affected by ALS: Physical 
Mobility; Activities of Daily Living and Independence; 
Eating and Drinking; Communication; and Emotional 
Functioning (Jenkinson, Peto, Jones, & Fitzpatrick, 2003). 
Criticism of the SIP, SIP/ALS-19 and the ALSAQ-40 
includes the fact that they are heavily weighted toward 
physical functioning and therefore fail to capture other 
factors related to QOL (Simmons et. al., 2006). The 
measures correspond too closely to measurements of strength 
and function; consequently, when the inevitable physical 
decline begins, so do the patient's QOL scores as measured 
by these instruments. 
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Schedule for the Evaluation of Individual Quality of 
Life. The Schedule for the Evaluation of Individual Quality 
of Life (SEIQoL) and the shorter SEIQoL-Direct Weighting 
(SEIQoL-DW) assess individualized QOL using a semi-
structured interview technique. The SEIQoL is a measure 
designed to elicit the value systems of individual 
respondents and to quantify QOL. This instrument is an 
interview-administered measure with three structured 
stages. Initially, respondents identify five domains of 
life that they recognize as important in relation to their 
present QOL. They then indicate the relative weight of each 
of these "elicited cues" in regard to their QOL. The SEIQoL 
has demonstrated the importance of nonphysical factors in 
assessing QOL. However, the instrument is designed to 
attain a greater level of individual subjectivity than is 
achieved with generic measures of QOL. Therefore it may not 
be useful when assessing large samples (Simmons et al., 
2006). 
Development Towards an ALS Specific Tool 
ALS-specific Quality of Life (ALSSQOL) Instrument. The 
Amyotrophic Lateral Sclerosis-Specific Quality of Life 
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instrument (ALSSQOL) was developed to reflect overall QOL; 
it is a measure that has proved valid and reliable across 
large samples of ALS patients. The ALSSQOL, which asks 
wide-ranging questions, is a 59-item questionnaire that 
uses a 0 to 10 point scale for each item. The least 
desirable situations are scored as a 0, and the most 
desirable are scored as a 10, resulting in scores ranging 
from 0-590 (Simmons et. al., 2006). 
The ALSSQOL was based on many of the principles of the 
MQOL; however, the ALSSQOL inquires more broadly about 
spirituality and religiousness. In addition to asking 
questions regarding physical symptoms, religiousness and 
spirituality, the ALSSQOL inquires about intimacy, 
loneliness, relationships, environment, social interaction, 
values, coping and interests, and desires/goals (Simmons et 
al., 2 00 6) . 
The ALSSQOL was developed at Penn State Hershey 
Medical Center. The evaluation of the ALSSQOL's 
psychometric properties was a prospective study involving 
seven university-based ALS centers. The ALSSQOL appears to 
be a valid instrument demonstrating concurrent, convergent, 
and discriminant validity for the overall instrument. 
Convergent validity was demonstrated for its subscales. The 
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ALSSQOL takes on average 15 minutes to complete with a 
range of approximately 10 to 25 minutes (Simmons et al., 
2006). 
ALSSQOL-Revised. Validation studies are currently 
underway for a shortened version of the ALSSQOL. Presently 
a multi-center study to validate a shorter, 50-item version 
of the ALSSQOL is being conducted. Thus far the ALSSQOL-R 
has shown promise as an effective instrument for measuring 
QOL in ALS patients. This time there are nine university-
affiliated ALS clinics involved in the study. In addition 
to validating the shorter 50-item ALSSQOL, the current 
studies aim to determine the relationship, if any, between 
hope, optimism, social problem-solving skills, relationship 
satisfaction, religiosity/spirituality and the QOL in 
caregivers of patients with ALS. The researchers intend to 
explore further the possibility of using the ALSSQOL-R via 
methods other than personal interview only; these include 
home completion of written or electronic questionnaires and 
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Definitions 
"Communication" is defined as the exchange of 
information between individuals, for example, by means of 
speaking, writing, or using a common system of signs or 
behavior (Merriam-Webster Online Dictionary, n.d.). 
Communication is one of the most difficult, yet necessary, 
skills that we as human beings learn. Communication occurs 
continuously throughout the course of one's day. Expressing 
one's needs, feelings, ideas, preferences, and opinions 
allows people to control and modify their environments. Any 
change in an individual's ability to speak can greatly 
impact these everyday expressions and impair that control. 
ALS patients have to modify how, when, and where they speak 
in order to be well understood; therefore, their sense of 
control can vacillate from one situation to the next. 
Assessing QOL in people with communication impairment 
is often difficult in health related research. Hilari and 
Byng (2001) claim that the materials used to assess QOL can 
often be linguistically complex. They also report that the 
way in which the materials are administered does not 
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usually facilitate the sharing of personal experiences by 
those with communication disabilities. 
Nonverbal Communication 
The exchange of thoughts and feelings does not always 
occur through the use of language. Nonverbal communication 
such as gestures, kinesics (body motions/posture), facial 
expressions, spatial relations, touch and display 
(presentation of self) are effective means of 
communication. It is necessary to stress to patients and to 
their families the importance of utilizing these nonverbal 
techniques to substitute for the loss of speech or to 
enhance impaired speech. Nonverbal communication 
techniques can, however, be very limiting. Nonverbal 
communication can be imprecise and interpretation is 
difficult especially if the two (or more) parties involved 
are not very familiar with one another. Additional 
impediments to the use of nonverbal communication include 
the difficulty in presenting complex information and the 
inability to communicate sarcasm. The need to be in fairly 
close proximity to those with whom you wish to communicate 
is essential. Nonverbal communication is effective only in 
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person and therefore text and telephone communication is 
prevented. 
Verbal communication is impaired in more than 80% of 
patients with ALS over the course of the disease (Leigh, 
Abrahams, Al-Chalabi, Arnpong, Goldstein, Johnson, et al., 
2003). ALS affects the strength and coordination of a 
patient's breath, vocal cords, tongue, lips and jaw, 
thereby creating challenges to his or her communicative 
ability (Carr-Davis, Blakely-Adams, & Corinbilt, 2005). 
Dysarthria is usually the earliest symptom presenting 
in patients with bulbar onset. As mentioned previously, it 
is unfortunately common for ALS patients to become 
anarthric within just a few months (Leigh, Abrahams, Al-
Chalabi, Arnpong, Goldstein, Johnson, et al., 2003). 
Communication can be unfavorably affected when a 
patient experiences the psuedobulbar symptoms of ALS. The 
exaggerated emotional responses they experience can be very 
disruptive and can hinder their ability to share or 
exchange information effectively with others. 
Pragmatics 

Communication & QOL in ALS 42 
Herbert Paul Grice, an American philosopher-linguist, 
was best known for his contributions to the study of 
meaning within language. Grice's work is considered one of 
the foundations of the modern study of pragmatics. 
Pragmatics, a subfield of linguistics developed in the 
1970s, is the study of how people use language. Every 
communicative act or speech act has two intents or 
meanings. One is the informative intent or the sentence 
meaning, and the other is the communicative intent or 
speaker meaning. Pragmatics is primarily concerned with 
bridging the explanatory gap between the sentence meaning 
and speaker's meaning. "Meaning is not something which is 
inherent in the words alone, nor is it produced by the 
speaker alone, nor by the hearer alone. Making meaning is a 
dynamic process, involving the negotiation of meaning 
between speaker and hearer, the context of the utterance 
(physical, social and linguistic) and the meaning potential 
of an utterance" (Thomas, 1995, p. 22). 
The ability to produce and understand a communicative 
act necessitates knowledge about social distance, social 
status between the involved speakers, and cultural 
knowledge. People constantly change their use of language 
in response to different contexts. When the ability to 
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communicate is impaired, as it is in patients with ALS, the 
opportunity to adapt to different settings and situations 
is severely challenged. 
Thomas (1995) states that speakers frequently mean 
more than simply what their words actually say. This may be 
a difficult aspect of communication for ALS patients 
because the message they may be trying to convey is not 
always facilitated by their non-verbal techniques. The 
physical impediments that ALS patients experience can make 
it difficult to control such aspects of communication as 
inflection, body positioning, gesturing, and touching. 
Because of muscle weakness, the facial expressions of ALS 
patients can be difficult to interpret correctly. So even 
when a patient's words are successfully understood there 
may still be information that he or she wishes to express 
that has been missed or misconstrued. Expressions rely on 
fairly minute differences in the proportion and positioning 
of facial features. Therefore, family, friends and 
healthcare providers of those with ALS must be extremely 
sensitive when attempting to interpret facial expressions. 
Maxims of Conversation 

Communication & QOL in ALS 44 
Grice (1967) proposed that conversations develop on 
the basis of a cooperative principle. This principle 
assumes that both speaker and hearer converse with a 
willingness both to deliver and to interpret a message. It 
is this cooperation that leads to successful communication 
(Thomas, 1995). For communication to be truly effective, it 
must be guided by specific rules. Therefore, in addition to 
the cooperation principle, Grice put forth a set of four 
conversational maxims: the maxim of quantity, the maxim of 
quality, the maxim of relevance and the maxim of manner. 
Maxim of Quantity. The maxim of quantity requires the 
speaker to give the right amount of information when he or 
she speaks. This speaker is expected to be not too brief or 
too verbose. This rule dictates that a contribution to a 
conversation be as informative as required, but that it 
should not be more informative than is appropriate for the 
given situation. 
Maxim of Quality. The maxim of quality is a matter of 
giving truthful information. One should not say what he or 
she believes to be false or what he or she cannot provide 
adequate evidence to support. Truthfulness is regarded as 
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the most important maxim on which all the others are 
dependent. However, the veracity of an ALS patient's 
statements should not be questioned simply because he or 
she has impaired speech. It is most likely to be an issue 
of inaccurate interpretation on the part of the listeners. 
Maxim of Relevance. The maxim of relevance requires the 
speaker to be relevant to the context and situation in 
which the conversation is currently taking place. It is 
important to recognize that the parties involved in the 
conversation determine relevance. The pathological laughing 
or crying that results from pseudobulbar affect may lead to 
overt violations of the maxim of relevance when ALS 
patients are displaying emotions that are clearly out of 
context. 
Maxim of Manner.The maxim of manner calls for speaking 
with brevity and clarity, yet maintaining logical order 
when conversing. It dictates that one should avoid obscure 
expressions and ambiguity. The maxim of manner is perhaps 
the most difficult maxim for adherence by ALS patients 
because of their potentially ambiguous or unclear 
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utterances. 
A maxim that is not adhered to is known as a non-
observance. If the speaker breaks a maxim the hearer then 
attempts to discern the speaker's implied meaning. The 
hearer does so based on the assumption that both speaker 
and hearer are observing the cooperative principle and are 
interested in communicating effectively. Often a speaker 
will intentionally fail to observe a maxim. This may occur 
to create a humorous situation or to avoid discomfort. 
Unfortunately, the breaking of a maxim for an ALS patient 
may not be volitional. Rather, the violation may be 
unavoidable, given speech and physical limitations. Even 
when an ALS patient does intend to break the rules and 
imply a meaning beyond the literal sense, the results can 
be unpredictable. For example, if asked, "How are you 
today?" a patient may reply, "I am great" even though he or 
she may clearly not be feeling great. However, this could 
be an example of the speaker (patient) so blatantly 
breaking the rule of quality (truthfulness) that he or she 
intended the hearer to pick up the meaning of the utterance 
not directly stated in words. For those whose quantity of 
speech may be limited and whose non-verbal techniques are 
impaired, it could be difficult to convey such sarcasm if 
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they should have to explain themselves further. 
Turn-Taking 
Another communication issue that is relevant in regard 
to ALS patients is the turn-taking behaviors displayed 
during conversations. Sacks, Schegloff and Jefferson (1974) 
were the first to recognize that conversations were highly 
organized social activities. They put forth two types of 
turn-allocation techniques: a) the current-speaker chooses 
the next speaker, or b) the next-speaker is allocated by 
self-selection. The time interval between the current-
speaker finishing and the next-speaker starting is known as 
reaction time latency. Initiative time latency is the 
duration between a current-speaker's completion and the 
start of a follow-up utterance by the same speaker (Sacks, 
Schegloff and Jefferson, 1974). As would be expected, there 
are various cultural norms dictating what is appropriate 
during these aforementioned intervals. Only by actively 
paying attention, looking and listening, can a prospective 
next-speaker appropriately incorporate himself or herself 
into the conversation. These are particularly important 
matters to acknowledge when attempting to converse with ALS 
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patients who have speech problems. Muscle weakness, aches, 
cramps, spasms, spasticity, excessive salivation and 
generalized fatigue can lead to conversational lulls that 
create communication discontinuity. To interject or change 
the subject of the conversation before the patient has had 
an opportunity to express him or herself completely can be 
construed as dismissive, ignorant or indifferent. Because 
there may be possible extended reaction time latency, ample 
opportunities must be provided for the patient to respond 
to previous statements or to introduce new topics. 
Augmentative and Alternative Communication (AAC) Methods 
Although most of the aforementioned losses (mobility, 
independence, future) are inevitable, it is possible that 
the healthcare team can aid ALS patients in maintaining 
their ability to communicate. Augmentative and Alternative 
Communication (AAC) refers to communication approaches that 
augment or supplement existing speech or act as an 
alternative to natural speech. Through AAC devices and 
compensatory strategies, ALS patients can learn to 
communicate very effectively. Among ALS patients with 
impaired verbal communication, 80% are so disabled that 
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they need AAC strategies to meet their daily communication 
needs (Yorkston, Beukelman & Ball, 2002). 
AAC can refer to any method that makes communication 
less challenging and more manageable. People use multiple 
communication strategies throughout the course of a day to 
emphasize and clarify their intentions. ALS patients may 
not be fortunate enough to have various strategies to 
choose from during daily discourse. AAC may be used along 
with gestures and facial expressions so that ALS patients 
may emphasize and clarify their messages. There are three 
different designations for AAC strategies: 
1. No-tech strategies 
2. Low-tech strategies 
3. High-tech strategies 
No-tech Strategies. These strategies are those that do 
not require the use of technology. Strategies include sign 
language, gestures, and eye gaze. Talking slowly and 
exaggerating one's movements when possible are effective 
no-tech interventions. 
Low-tech Strategies. Low-tech refers to communication 
strategies that employ items not requiring the use of 
electrical power. Examples of low-tech strategies include 
manual communication boards and eye gaze boards. These may 
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often be the preferred methods because higher levels of 
energy, technical skills and knowledge are not needed as 
they would be with the more sophisticated equipment. The 
use of simple communication boards with alphabet letters, 
words and phrases, or symbols and pictures representing 
specific messages can be very effective low-tech 
strategies. 
High-tech Strategies. High-tech refers to 
communication strategies such as computer-assisted devices. 
These devices can include a wide range of computerized 
systems that can amplify the patients' voices or can create 
their own synthesized voices. Personal computers can be 
modified and used as communication devices simply by 
installing communication software. 
Research Hypothesis 
There are two hypotheses for the current study. They 
are as follows: 
1. QOL will differ among ALS patients with varying 
levels of speech, swallowing, and salivation functioning, 
2. Patients with less impairment in these aspects of 
physical functioning will report better QOL. 
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Significance of the Research 
The current study examined the self-perceived QOL in 
ALS patients. Precise focus was on communication impairment 
and the effect that it has or does not have on QOL. This 
research is important because it is expected the findings 
will show that QOL is adversely affected by impaired 
communication abilities. Having this knowledge will allow 
mental health providers to tailor time-sensitive 
interventions more appropriately, perhaps enhancing ALS 
patients QOL. 
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Methodology 
Participants 
A total of 342 ALS patients from seven university-
based ALS centers chose to participate in the ALSSQOL 
study. There were 226 men (66%) and 116 women (34%) 
involved. The patients' ages ranged from 27 to 87 years old 
(median= 58.0, mean= 57.6, standard deviation= 12.8). At 
the inception of the study, the symptom duration varied 
from 1 month to 237 months (median= 24.5, mean= 37.4, SO 
= 37.4). There was symptom duration of <60 months in 84% of 
patients and <120 months in 95% of patients (Simmons et 
al., 2006). 
Criterion for Inclusion in the Study 
From these centers, all patients who were willing to 
participate were included if they met the following 
criteria: 1) age 18 years or older; 2) clinically definite 
ALS, clinically probable ALS, or clinically probable ALS, 
laboratory-supported; 3) fluency in English at the sixth 
grade level or higher (Simmons et al., 2006). 
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Criterion for Exclusion in the Study 
Patients were excluded if an evaluating physician or 
psychologist determined that they suffered from a dementia 
or other cognitive impairment that was sufficient to 
preclude the granting of informed consent and participation 
in the study (Simmons et al., 2006). 
Overview 
IRB approval was obtained at each of the independent 
institutions. Research assistants at the multiple sites 
were responsible for data collection duties that included 
introducing the study to patients and caregivers, 
obtaining/verifying informed consent and administering the 
questionnaires. Ideally it was a trusted member of the 
healthcare team, such as the physician or clinic nurse, who 
would initially approach the patient and introduce the 
basics of the study. The patients may even have received 
correspondence from the ALS clinic prior to his or her 
scheduled appointment. The various ways in which patients 
responded to the questionnaires included answering orally, 
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through pointing to the varied responses or through 
blinking. As the research assistants read through the 
options, the patients would have blinked upon hearing their 
desired responses or blinked the number of times necessary 
to indicate their choices. By administering all of the 
patient questionnaires in interview format, participation 
was increased and the burden on the patients was kept to a 
minimum. 
Description of Measures and Forms 
ALS Functional Rating Scale (ALSFRS)/ALSFRS-Revised. 
The ALSFRS is a validated rating instrument for monitoring 
the progression of disability in patients with ALS. It is a 
5-point scale consisting of 10 items, each of which is 
scored from 0 (unable/dependent) to 4 (none/normal). 
Individual item scores are then summed to produce a 
reported score between 0 (worst) and 40 (best). The rating 
scale evaluates bulbar function, motor function, and 
respiratory function. The ALSFRS shows close agreement with 
objective measures of muscle strength and pulmonary 
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function. The scale sh6ws test-retest reliability and has 
proved to be consistent (Cedarbaum & Stambler, 1997). 
However, one identified weakness of the original 
ALSFRS was the disproportionate amount of weight it 
allotted to limb and bulbar dysfunction over respiratory 
dysfunction. The revised version the ALSFRS-R incorporates 
additional assessments of dyspnea, orthopnea and the need 
for ventilatory support. The ALSFRS-R retains the 
properties of the original scale and shows strong internal 
consistency and construct validity. Although both 
instruments are on a 5-point scale, the revised version 
consists of 12 items, each of which is scored from 0 
(unable/dependent) to 4 (none/normal). Summed scores total 
between 0 (worst) and 48 (best). The rating scale evaluates 
bulbar function, motor function, and respiratory function. 
The ALSFRS and the ALSFRS-R are validated clinical rating 
scales. They have been shown to track progression of 
disability accurately in ALS and have even been shown to be 
a predictor of survival in ALS. Both instruments take just 
a few minutes to administer; this is accomplished easily at 
each clinic visit by a neurologist or a nurse (Cedarbaum, 
Stambler, Malta, Fuller, Hilt, & Thurmond, 1999). 
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For all of the variables on the ALSFRS, a score of a 4 
indicates normal functioning. A score of 3 for speech 
indicates detectable speech disturbances. A score of 2 
identifies intelligible speech that requires repeating. 
Speech that is combined with non-vocal communication is 
scored a 1. Loss of all useful speech is scored a 0. 
A score of 3 for salivation indicates slight, but 
definite excess of saliva in mouth. These patients may have 
problems with nighttime drooling. A score of 2 is given 
when there is moderately excessive saliva that may lead to 
minimal drooling. A score of 1 is assigned when there is 
marked excess of saliva with some drooling. Marked drooling 
that requires the constant use of a tissue or handkerchief 
would be assigned a score of 0. 
When assessing the ability to swallow, a score of 3 
would be given for early eating problems with occasional 
choking episodes. Dietary consistency changes would 
necessitate a score of 2. A score of 1 would be assigned 
when a supplemental feeding tube needs to be put in place. 
A score of 0 is given when it is determined that the 
patient can no longer eat anything by mouth and he or she 
begins to receive parenteral (via intravenous or 
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intramuscular route) or enteral (using the gastrointestinal 
tract) feedings. 
All the participants in the ALSSQOL validation studies 
were administered the ALSFRS. Three of the ten items on the 
ALSFRS were examined specifically for the current study: 
Swallowing, Speech and Salivation. 
Manual Muscle Test. Manual muscle testing (MMT) is an 
important part of the physical examination. It is a 
technique that is beneficial for establishing a diagnosis, 
prognosis, and treatment of neuromuscular and 
musculoskeletal disorders. It is the most frequently used 
method for documenting impairments in a patient's muscle 
strength (Cuthbert & Goodheart, 2007). 
MMT is a scored neurological examination. The full 
test, which examines 34 muscles, scores these muscles from 
0 to 5. For the purposes of our study, four muscle groups 
were assessed: Arm (shoulder) abductors, wrist extensors, 
Hip flexors and ankle dorsiflexors. All MMT assessments are 
conducted bilaterally. This is important because ALS can 
affect muscle groups incongruently. 
The scale is composed both of subjective and of 
objective factors. The subjective criteria include both the 
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standard amount of resistance as determined by the examiner 
and the amount of resistance the client can tolerate. The 
objective criteria for establishing an MMT score include 
the patient's abilities in completing the available range 
of motion, holding the designated position and moving 
against gravity. 
Cuthbert and Goodheart (2007) assert that MMT is both 
a science and an art and must be performed according to 
precise testing protocol. Proper positioning, consistent 
timing and pressure, nonpainful contact, and the avoidance 
of preconceived impressions regarding outcome must be 
employed throughout the MMT. 
The grading system for the MMT comprises both a 
numerical score and a qualitative score. The numerical 
scores range from 0 to 5. The qualitative scores, with 
their corresponding numerical scores, are as follows: Zero 
(no activity/0), Trace activity (1), Poor (2), Fair (3), 
Good (4), and Normal (5). The following more specific scale 
is put forth by the Medical Research Council (MRC) : No 
contraction (0), Flicker or trace contraction (1), Active 
movement with gravity eliminated (2), Active movement 
against gravity (3), Active movement against gravity and 
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resistance (4), and Normal power (5; Great Lakes ALS Study 
Group, 2003). 
Modifications to the measurements are possible for 
grades 3, 4 and 5. Plus and minus indicators modify the 
whole number scores by a third of a grade. Grade 5 can be 
modified only by a minus sign (5- 4.67); however, grades 
3 and 4 can be modified either by a plus or by a minus. The 
purpose of the plus and minus modifiers is to represent a 
muscle that is slightly stronger or weaker than the whole 
number would indicate. 
Statistical Analysis 
The data was entered into a computer-based statistical 
package, Statistical Package for the Social Sciences (SPSS, 
15.0, 2006), to conduct statistical analyses. The various 
statistical analyses of the data included 1) one-way 
analysis of variance (ANOVA), 2) descriptive statistics, 3) 
frequency statistics, 4) univariate analysis of variance 
for between-subject factors for all three independent 
variables (speech, swallowing, and salivation), and 5) the 
Tukey HSD test, which was used in the post-hoc tests of the 
three independent variables. 
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A one-way ANOVA is used to test for differences among 
three or more independent groups. When statistically 
significant, the ANOVA will indicate that there is a 
difference somewhere; however, the specific pairs of means 
that are significantly different are not known. To 
determine this information a post hoc test is used. To 
analyze our results further and to find out where the 
differences between means lie, the Tukey HSD test was 
utilized. The Tukey HSD test is used for testing the 
significance of unplanned pairwise comparisons. When 
multiple significance tests are completed, the chance of 
finding a "significant" difference just by chance 
increases. Tukey's HSD test is a method of ensuring that 
the chance of finding a significant difference in any 
comparison is maintained at the alpha level of the test. 
Descriptive statistics are used to describe the basic 
features of the data in a study. Descriptive statistics 
(such as means, medians and modes) were utilized to 
describe the personal characteristics of the sample. 
Inferential statistics are used to determine 
conclusions that reach beyond the immediate data. These 
types of statistics are used to draw inferences from a 
sample about a population. The statistical analyses of the 
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inferential data collected during the validation of the 
ALSSQOL included analysis of variance (ANOVA) and were used 
during this current study. 
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Results 
Descriptive Statistics 
Age. The ages for the study sample ranged from 27 to 
87 years old. The mean of the sample was 57.57 years old. 
The standard deviation was 12.847 years. 
Duration of Illness. The minimum duration of ALS 
symptoms at the time of enrollment in the study was 1 
month. The longest duration of ALS symptoms in the sample 
was 237 months (19.75 years). The mean duration of symptoms 
was 37.37 months (3.11 years) for our study sample with a 
standard deviation of 37.40 months (3.11 years). There were 
bi-modal duration results for the sample. Symptom durations 
of 13 months and 16 months were reported by 13 patients. 
Gender. Subjects were excluded from the final analysis 
if there was any data that was missing. Gender data was 
missing on 14 of the subjects so that information from 342 
valid subjects was used. The gender distribution for the 
total sample (n = 342) consisted of 226 males (66.1%) and 
116 females (33.9%). 
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Marital Status. Marital status distribution consisted 
of 274 individuals who were married (80.1%), 31 who were 
divorced (9.1%), 15 who were never married (4.4%), 3 who 
were separated (0.8%), and 19 who were widowed (5.6%). 
Race. The total sample population (n= 342) showed a 
race distribution of 317 subjects who were Caucasian 
(92.7%), 7 who were Hispanic (2.0%), 10 subjects who were 
African American (2.9%), 6 who were Asian/Pacific Islander 
(1.8%), 1 who indicated "Other" (0.3%) and 1 who indicated 
"Prefer not to answer" (0.3%). 
Manual Muscle Testing Scores. The total number of 
patients with valid MMT scores was 340. A total of eight 
muscle tests were conducted on each of these clients. They 
included bilateral assessments of the arm (shoulder) 
abductors, wrist extensors, hip flexors and ankle 
dorsiflexors. The minimum MMT score was 0 (no contraction), 
which indicates that no contractile activity can be felt in 
the gravity eliminated position. The maximum MMT score was 
5 (normal power), which indicates that the patient can hold 
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the position against maximum resistance and through 
complete range of motion. 
Amyotrophic Lateral Sclerosis Functional Rating Scale 
(ALSFRS). Valid results were obtained for 342 of the 
subjects in the sample population. The minimum score for 
the ALSFRS was 1, and the maximum score recorded was 40. 
The mean score for the ALSFRS was 26.96. The standard 
deviation was 7.157. 
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Table 1 
Dependent Variable (Speech): ALSSQOL tota/46 items 
(I) Speech (J) Speech Sig. 
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Table 2 
Dependent Variable (Salivation): ALSSQOL total 46 items 
TukeyHSD 











































*The mean difference is significant at the .05 level. **Approaching statistical significance. 
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Table 3 
Dependent Variable (Swallowing): ALSSQOL total46 items 
(I) Swallowing (J) Swallowing 
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Table 4 
ALSFRS Items by ALSSQOL Total 
N Mean SD Minimum Maximum 
Speech 0 25 301.92 60.08 176.00 403.00 
1 15 312.27 74.79 162.00 440.00 
2 45 323.47 49.94 218.00 404.00 
3 117 318.49 58.28 182.00 429.00 
4 136 343.99 55.70 209.00 454.00 
Total 338 
Salivation 0 11 317.91 50.48 207.00 403.00 
1 20 294.55 59.22 176.00 394.00 
2 37 326.03 43.71 218.00 403.00 
3 78 316.37 63.15 162.00 429.00 
4 192 337.01 57.74 203.00 454.00 
Total 338 
Swallowing 0 10 314.20 41.70 239.00 380.00 
1 18 313.22 56.15 207.00 394.00 
2 41 298.15 54.40 176.00 398.00 
3 104 319.33 57.23 162.00 440.00 
4 165 343.15 57.46 205.00 454.00 
Total 338 
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Table 5 
ALSFRS Descriptives 
N Mean SD Minimum Maximum 
Speech 0 25 18.04 8.97 1 32 
1 15 22.60 7.38 7 34 
2 45 24.49 7.35 8 37 
3 117 26.82 6.44 11 39 
4 136 30.13 5.12 14 40 
Total 338 
Salivation 0 11 22.09 6.73 10 32 
1 20 18.50 9.28 1 33 
2 37 25.22 7.36 2 36 
3 78 25.81 7.45 8 37 
4 192 29.00 5.75 11 40 
Total 338 
Swallowing 0 10 13.30 10.02 1 27 
1 18 20.28 7.45 7 31 
2 41 22.93 6.33 6 35 
3 104 26.53 6.76 11 38 



























** Correlation is significant at the 0.01level (2-tailed). 

Table 7 
One-Way ANOVA: Between-Subject Factors 
Speech Between Groups 
Within Groups 
Total 
Salivation Between Groups 
Within Groups 
Total 
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Discussion 
The goal of this investigation was to determine 
whether or not QOL differs among ALS patients with varying 
levels of impairment in bulbar functioning (speech, 
swallowing, and salivation) and to verify whether or not 
patients with less impairment in these aspects of physical 
functioning will report better QOL. The results of this 
study that have been presented in the previous chapter 
demonstrate that there are significant differences in QOL, 
relative to level of bulbar functioning. This chapter will 
summarize the study and discuss the research findings. 
Study limitations and directions for future research on QOL 
and ALS are recommended. 
Discussion of Research Findings 
A weak relationship exists between physical 
functioning and QOL (r = .257; p = ~ .001). However, when 
comparing those with no impairment in bulbar functioning to 
those with various levels of bulbar impairment, the 
greatest difference in QOL is between those ALS patients 
who have no impairment and those who are demonstrating the 
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first signs of impairment. In other words, there was 
significant difference or differences approaching 
significance across all three items (speech, salivation and 
swallowing) when comparing groups with no impairments 
(ALSFRS scores of 4) to those with early, slight or 
detectable disturbances (ALSFRS scores of 3). There was 
basically no significant difference between varying groups 
who have evidence of some impairment. After some impairment 
is recognized, QOL is fairly stable across the groups. This 
suggests that the initial signs of impairment have the 
biggest impact on ALS patients' QOL. The three ALSFRS items 
of concern are discussed specifically in the following 
paragraphs. 
Through post hoc testing it was discovered that in 
regard to speech functioning there was a significant 
difference (.007) in QOL for ALS patients with no 
functional impairment (ALSFRS score of 4; mean ALSSQOL 
score= 343.99) when they are compared with those having no 
functional speech (ALSFRS score of 0; mean ALSSQOL score 
3 01. 92) . 
A significant difference (.004) was also observed in 
QOL for ALS patients with no functional impairment (ALSFRS 
score of 4) when compared with those patients initially 
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experiencing detectable speech disturbances (ALSFRS score 
of 3; mean ALSSQOL score = 318.49). This can be perceived 
as a crucial intervention time in working with the ALS 
patient. A change in the patient's self-perceived QOL was 
readily identified; therefore, planning and education 
should target this time period specifically. 
As previously discussed, there was an observed 
difference approaching statistical significance (.061) 
between those with no impairment in salivation management 
and functioning (ALSFRS score of 4; mean ALSSQOL score of 
337.01) and with those having slight, but definite excess 
of saliva in their mouths (ALSFRS score of 3; mean ALSSQOL 
score of 316.37). 
Post hoc testing further demonstrated, that relative 
to salivation management and functioning, there was a 
significant difference (.016) in QOL for ALS patients when 
comparing those with no functional impairment (ALSFRS score 
of 4; mean ALSSQOL score of 337.01) with those having 
marked excess of saliva with some drooling (ALSFRS score of 
1; mean ALSSQOL score of 294.55). However, those groups 
with marked drooling who require constant tissue or 
handkerchief use (ALSFRS score of 0) had a mean ALSSQOL 
score of 317.91. This is a higher ALSSQOL score than those 
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with marked excess of saliva with some drooling (294.55) 
and those with slight, but definite excess of saliva in 
their mouths (316.37). This may be evidence of acceptance 
on behalf of the ALS patients regarding their progression 
of salivation-related symptoms. 
Post hoc testing of swallowing function demonstrated 
significant differences (.008) between those ALS patients 
who have normal eating habits with no impairment (ALSFRS 
score of 4; mean ALSSQOL score of 343.15) and those who 
displayed early eating problems such as occasional choking 
(ALSFRS score of 3; mean ALSSQOL score of 319.33). 
However significant differences (.000) were also 
observed when comparing those who have normal eating habits 
and no impairment (ALSFRS score of 4; mean ALSSQOL score of 
343.15) with those experiencing dietary consistency changes 
(ALSFRS score of 2; mean ALSSQOL score of 298.15). This 
appears to indicate that when the ALS patients initially 
have to make chapges in the types of food they consume, it 
is a significant event with definite changes in self-
reported QOL that should be recognized and addressed. 
Noteworthy is the fact that those with supplemental tube 
feedings (ALSFRS score of 1; mean ALSSQOL score of 313.22) 
and those who eventually receive nothing by mouth report 
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higher QOL (ALSFRS score of 0; mean ALSSQOL score of 
314.20) than those who have to make dietary consistency 
changes (ALSFRS = 2; ALSSQOL mean= 298.15). This can 
possibly be explained by the continued acceptance of ALS 
patients regarding the progression of their swallowing 
symptoms and the fact that QOL may improve after they 
receive tube feedings because they are no longer choking, 
sputtering, and aspirating their food. This data may have 
an impact on the way in which the medical community treats 
ALS patients with swallowing impairments. Interventions 
meant to delay the introduction of a feeding tube may not 
necessarily be improving an ALS patient's QOL. 
These results are important because there is not a 
linear relationship between physical functioning and QOL; 
therefore, the individual symptom progression needs to be 
examined specifically. There appear to be identified areas 
during which healthcare providers can intervene with ALS 
patients. Guidance, targeted information and preparation 
can be provided to the patients to assist them before they 
experience the levels of bulbar dysfunction that were 
identified as impacting QOL in the greatest degree. Problem 
solving skills can be introduced or reinforced. During 
these preliminary transition times decision clarification 
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can be obtained regarding difficult choices that the 
patient and family may have to make. Isolation and 
confusion are potential obstacles during these transitions 
from one level of functioning to another. Timely and well-
planned interventions may have favorable effects on ALS 
patient self-reported QOL. 
ANOVA revealed that self-reported QOL varied according 
to level of functioning for speech F(4,333) = 5.13, p 
=.001; swallowing F(4, 333)= 6.88, p=.OOO; and salivation, 
F(4,333)= 3.75, p =.000. The between-group differences for 
speech, swallowing and salivation are all significant (p < 
. 05). 
The mean age for the sample is fairly consistent with 
the general population of ALS patients. Most people who 
develop ALS are between 40 and 70 years of age. The average 
age at the time of diagnosis is 55; however, cases do occur 
in men and women in their twenties and thirties (ALS 
Association, 2007). 
The mean duration of symptoms was 37.37 months (3.11 
years) with a standard deviation of 37.40 months (3.11 
years). The average life expectancy of a person with ALS is 
24 months (2 years) to 60 months (5 years) from time of 
diagnosis. The ALS Association (2007) reports that 50% of 
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those diagnosed with ALS will live at least 36 months (3 
years) or more after the initial diagnosis. Twenty-five 
percent will live 60 months (5 years) or more after 
diagnosis. Only 10% of those diagnosed with ALS will live 
(120 months) 10 years and beyond after the initial 
diagnosis. The mean duration of symptoms for this sample 
population is 37.37 months. Therefore the mean duration for 
the sample falls within the average life expectancy of all 
persons with ALS. However, there appear to be obvious 
outliers (e.g. 237 months) in this sample in regard to 
duration. It should also be noted that the subjects' 
duration of symptoms was obtained through self-report and 
not through medical records review. Additionally, subjects 
were not followed until death for this study. 
The male to female ratio of 66.1% to 33.9% in the 
sample appears to be representative of the general ALS 
population. According to the ALS CARE Database, 60% of the 
people with ALS in the Database are men (ALS Association, 
2007) . 
In the sample population (92.7%) and in the ALS CARE 
Database (93%), a large majority of the ALS patients are 
Caucasian. This data is representative of patients seen in 
many university-based, multidisciplinary ALS clinics; 
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however, the data may or may not be indicative of the 
general ALS population. The fact remains that it is not 
known whether or not race and ethnicity determine an 
individual's level of risk in developing ALS (Logroscino & 
Armon, 2007). It may be that minorities are 
underrepresented in these studies because they do not have 
the opportunities or even the desire to partake in such 
studies. They may have limited access to such care. 
Perhaps Caucasians for one reason or another (environment, 
genetics, lifestyle, etc ... ) are just more likely to develop 
ALS. Even though ALS may be more prevalent in one race or 
ethnicity than another, it does, however, occur throughout 
the world and affects people of all races, ethnic 
backgrounds and socioeconomic categories. Essentially, ALS 
strikes without prejudice. It is recognized that in this 
particular study there is a majority of English speaking, 
Caucasian clients. Conceivably, this may be an accurate 
representation of the general ALS population. 
The mean MMT score for the sample was 3.69 with a 
standard deviation of 1.10. This is interpreted to mean 
that the average ALS patient in this sample received a 
grade indicating slightly less than active movement against 
gravity and resistance (4- = 3.67). 
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The MMT data examined for this particular study did 
not include the composite scores for the eight muscle 
tests. Total scores are not known. Furthermore, it is not 
known specifically the types of physical impairments that 
the sample population was experiencing. There is no doubt 
that they were varied. It is not known whether or not a 
particular patient was dealing primarily with upper or 
lower limb involvement. Nor was it known whether or not he 
or she had significant differences between right and left 
sided strength. It is expected that a patient with lower 
limb MMT scores of 3 or less would generally need 
assistance with walking. Additionally, upper limb MMT 
scores of 3 or less would most certainly indicate that a 
patient needed assistance with completing his or her 
activities of daily living. 
ALSFRS comparisons are made with the patient's status 
prior to the onset of the disease, not with status at the 
last visit. The patients in this study sample demonstrated 
the greatest bulbar impairments in their speaking ability 
(mean= 2.96). Swallowing ability (mean= 3.17) was the 
second most impaired of the bulbar functioning. The least 
amount of impairment was in patients' ability to control 
saliva (mean 3. 2 4) . 
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Limitations of the Study 
There are a number of potential limiting factors 
identified for this study. Potential limiting issues 
include the fact that our data was obtained from the 
ALSSQOL validation study, conducted across seven 
university-based ALS Centers. The population involved in 
the study was made up of volunteer patients; these may not 
be representative of the typical ALS patient. 
From the clinics, there were a limited number of 
patients (>15%) who declined to participate in the study; 
this, therefore, is still an issue to be considered. Those 
who chose not to participate could very well have had a QOL 
different from those included in the study (Simmons et al., 
2006). 
The ALSSQOL were administered in a personal interview 
format to patients who might have been fatigued, hurried, 
upset, nervous, or otherwise distracted, despite the 
researchers best attempts to optimize the environment. All 
of the sites involved in the study are multidisciplinary 
settings. The patients may come into the office so rarely 
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that many providers are scheduled to see them on the same 
day. 
Another limitation that threatens the ability to 
generalize from the study's results (external validity) is 
the fact that the majority of the patients were English 
speaking, Caucasian clients without dementia or without 
considerable cognitive deficits. It may be difficult to 
infer with any certainty that the underrepresented 
populations who have ALS, such as minorities, non-English 
speaking patients, and those with cognitive impairments 
would benefit in the same manner from the results of the 
ALSSQOL studies. 
Recommendations for Future Study 
An area of future consideration should be the effect 
that the loss or impairment of handwriting to communicate 
has on an ALS patient's QOL. 
Bulbar symptoms can present at the onset of ALS or 
towards the end of the disease course. Future research 
should examine how the timing of onset affects the QOL of 
ALS patients. 
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Another area of consideration for future study would 
be the utilization of the ALSSQOL for longitudinal studies. 
We are currently comparing individuals who are in myriad 
stages of ALS. It would be scientifically relevant to 
follow a number of individuals and to administer the 
ALSSQOL at various points throughout the disease 
progression to track their self-reported QOL. 
Future studies should also include an examination of 
the significance of each change for ALS patients as they 
progress from normal level of functioning on the ALSFRS 
(item score 4) through each level of impairment (item 
scores 3, 2, 1, and 0). Researchers should investigate ALS 
patients' mindsets as they prepare to experience each of 
the transitions during this fairly predictable disease 
process. 
Conclusions 
In spite of the aforementioned limitations, it appears 
that this study's hypotheses have led to significant 
results. QOL does appear to be affected by the varying 
levels of impairment in speech, in salivation and in 
swallowing that accompany ALS. It is too broad a statement 
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to insist that QOL is not related to physical function. As 
this research has demonstrated, there are times when ALS 
patients self-reported QOL is adversely affected by 
physical impairments. However, the relationship between QOL 
and physical functioning is not linear; therefore, specific 
interventions should be planned for patients during the 
problem areas that have been identified. The expectation 
exist that future studies will expand upon these results. 
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Appendix A 
Sample Questions from the ALSSQOL 
Negative Emotion: 
Please rate the following statements according to how 
much you have felt or experienced what is described. Please 
respond about how you have felt or what you have 
experienced over the past week. 
Not at Very 
All Much 
22. I have been depressed. 0 1 2 3 4 5 6 7 8 9 10 
31. I have felt hopeless. 0 1 2 3 4 5 6 7 8 9 10 
Intimacy: 
The following statements are about emotional intimacy 
(for example, sharing deep, private thoughts; feeling 
connected). Please think about your experiences with or how 
you have felt about emotional intimacy in the past week, 
and use the scales provided below to respond. 
Not at Very 
All Much 
42. My desire for emotional 0 1 2 3 4 5 6 7 8 9 10 
has been strong. 
Satisfaction with Relationships and the Environment: 
Please rate the following statements according to how 
much you have felt or experienced what is described. Please 
respond about how you have felt or what you have 
experienced over the past week. 
Not at Very 
All Much 
26. Relationships with those 0 1 2 3 4 5 6 7 8 9 10 
closest to me have been 
satisfying. 
33. I have enjoyed the 0 1 2 3 4 5 6 7 8 9 10 
beauty of my surroundings. 
Religiosity: 
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Please rate the following statements according to how 
much you have felt or experienced what is described. Please 
respond about how you have felt or what you have 
experienced over the past week. 
Not at Very 
All Much 
23. My religion has been a 0 1 2 3 4 5 6 7 8 9 10 
source of strength or 
comfort to me. 
Physical Functioning: 
Please rate the following statements according to how 
strongly you agree or how strongly you disagree with each 
of them. Please respond about how you have felt or what you 
have experienced over the past week. 
Not at Very 
All Much 
10. I have felt physically 0 1 2 3 4 5 6 7 8 9 10 
terrible. 
Bulbar Functioning: 
Please rate the following symptoms and experiences 
according to how much of a problem each has been for you. 
Please respond about how you have felt or what you have 
experienced over the past week using the scale provided. 
Not at Very 
All Much 
3. Eating. 0 1 2 3 4 5 6 7 8 9 10 
4. Excess saliva. 0 1 2 3 4 5 6 7 8 9 10 
6. Speaking. 0 1 2 3 4 5 6 7 8 9 10 
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Appendix B 
ALS Functional Rating Scale 
1. Speech 
4 Normal speech process 
3 Detectable speech disturbance 
2 Intelligible with repeating 
1 Speech combined with non-vocal communication 
0 Loss of useful speech 
2. Salivation 
4 Normal 
3 Slight but definite excess of saliva in mouth; may have nighttime 
drooling 
2 Moderately excessive saliva; may have minimal drooling 
1 Marked excess of saliva with some drooling 
0 Marked drooling; requires constant tissue or handkerchief 
3. Swallowing 
4 Normal eating habits 
3 Early eating problems-occasional choking 
2 Dietary consistency changes 
1 Needs supplemental tube feeding 
0 NPO (exclusively parenteral or enteral feeding) 
4. Handwriting 
4 Normal 
3 Slow or sloppy; all words are legible 
2 Not all words are legible 
1 Able to grip pen but unable to write 
0 Unable to grip pen 
Sa. Cutting Food and Handling Utensils (patients without gastrostomy) 
4 Normal 
3 Somewhat slow and clumsy, but no help needed 
2 Can cut most foods, although clumsy and slow; some help needed 
1 Food must be cut by someone, but can still feed slowly 
0 Needs to be fed 
5b. Cutting Food and Handling Utensils (alternate scale for patients with 
gastrostomy) 
4 Normal 
3 Clumsy but able to perform all manipulations independently 
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2 Some help needed with closures and fasteners 
1 Provides minimal assistance to caregiver 
0 Unable to perform any aspects of task 
6. Dressing and Hygiene 
4 Normal function 
3 Independent and complete self-care with effort or decreased efficiency 
2 Intermittent assistance or substitute methods 
1 Needs attendant for self care 
0 Total dependence 
7. Turning in Bed and Adjusting Bed Clothes 
4 Normal 
3 Somewhat clumsy, but no help needed 
2 Can tum alone or adjust sheets, but with great difficulty 




3 Early ambulation difficulties 
2 Walks with assistance 
1 N onambulatory functional movement 
0 No purposeful leg movement 
9. Climbing Stairs 
4 Normal 
3 Slow 
2 Mild unsteadiness or fatigue 
1 Needs assistance 
0 Cannot do 
10. Breathing 
4 Normal 
3 Shortness of breathe with minimal exertion (walking, talking, etc ... ) 
2 Shortness of breathe at rest 
1 Intermittent (e.g. nocturnal) ventilatory assistance required 
0 Ventilator dependent 

